Key facts
- It has raised $270.0M; the latest was PE Growth/Expansion ($270.0M) in Apr 2026.
- Notable investors include Biotechnology Incubation Centre, Everstone Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Apothecon Pharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Apothecon Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apothecon Pharmaceuticals
Manufacturer of pharmaceutical products intended to serve regulated global healthcare markets. The company develops active pharmaceutical ingredients, peptides and complex finished dosage forms under government practice standards, thereby enabling compliant supply of specialized medicines worldwide.
- Sector
- Healthcare
- HQ
- Vadodara, India
- Founded
- 2003
- Employees
- 501
- Website
- apotheconpharma.com/
- Ownership
- Privately Held (backing)
Apothecon Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apothecon Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apothecon Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.